Early allograft dysfunction (EAD) after orthotopic liver transplantation (OLT) causes marked morbidity and mortality. We conducted a prospective pilot study to assess the safety and efficacy of molecular adsorbent recirculating system (MARS) in treatment of EAD after OLT. Twelve consecutive adult li
Retracted Fenoldopam in critically ill patients with early renal dysfunction: A crossover study
โ Scribed by Gian Paparcuri; Miguel Cobas; Maria De La Pena; Erik Barquist; Albert Varon
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 2011
- Tongue
- English
- Weight
- 98 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0090-2934
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Retraction: The following article from Dialysis & Transplantation, 'Fenoldopam in critically ill patients with early renal dysfunction: A crossover study' by Gian Paparcuri, Miguel Cobas, Maria De La Pena, Erik Barquist and Albert Varon, published online on March 8, 2011 in Wiley Online Library (wileyonlinelibrary.com), and in Volume 40, pp. 164โ167, has been retracted through agreement between the first author, the Editors, Andrew Z. Fenves and Larry B. Melton, and Wiley Periodicals, Inc. The retraction has been agreed due to duplicate publication in another journal.
๐ SIMILAR VOLUMES
Nine patients at risk for critical illness polyneuropathy (CIP) were included in a prospective study. We performed nerve conduction studies, electromyography, and a stimulation single-fiber electromyography (SFEMG). Five of 9 patients were diagnosed as CIP because they developed abnormal spontaneous
## Background: Chemotherapy options for the patients with advanced urothelial carcinoma and renal dysfunction are limited. the authors performed a phase ii trial of paclitaxel plus carboplatin in patients with advanced carcinoma of the urothelium and renal dysfunction. ## Methods: Forty-two patie